Related Experiment Video
Updated: Sep 5, 2025

04:55
Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
Published on: September 11, 2018
10.9K
Unintentional Pediatric Lithium Exposure: A 15-Year Retrospective Analysis
Pediatric Emergency Care
|July 8, 2022
Summary
Unintentional pediatric lithium ingestions are typically exploratory and benign, with most children experiencing no symptoms. Even with detectable lithium levels, isolated exposures appear safe, warranting further research for risk stratification.
Area of Science:
- Pediatric Toxicology
- Environmental Health
- Clinical Pharmacology
Background:
- Lithium exposure in children is rare and its effects are not well understood.
- Accidental or exploratory ingestions pose a unique challenge in pediatric care.
Purpose of the Study:
- To examine the clinical effects and outcomes of unintentional lithium ingestions in patients up to 16 years old.
- To characterize the safety profile of pediatric lithium exposure.
Main Methods:
- A single-state Poison Control System database was queried for pediatric lithium exposures managed in healthcare facilities from 2006-2021.
- Inclusion criteria focused on acute, oral lithium exposure in individuals 16 years or younger.
Main Results:
- 118 cases were analyzed, with 97% of patients 7 years or younger; 96% were exploratory ingestions.
- 85% of patients had no coded effects; 3% experienced mild to major effects, all associated with polydrug ingestions and fully recovered.
- Only 28% of available serum lithium concentrations were detectable, with 4 cases being supratherapeutic; no morbidity or mortality was reported.
Conclusions:
- The majority of unintentional pediatric lithium ingestions are exploratory and asymptomatic.
- Isolated lithium exposures appear benign, even with detectable serum concentrations.
- Further research is needed to establish clear guidelines for home care versus healthcare facility evaluation.
More Related Videos
Related Concept Videos
Mania and Antimanic Drugs: Overview
318
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
318
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
290
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
290
Factors Affecting Drug Response: Overview
2.2K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.2K
Pharmacovigilance
974
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
974

